BONESUPPORT AB is a Scandinavian orthobiologics company that develops and markets CERAMENT®, an innovative range of radiopaque injectable osteoconductive and drug-eluting bioceramic products that have a proven ability to heal defects by remodeling to host bone in six to twelve months.
Latest Press Release
Change in number of shares and votes in BONESUPPORT HOLDING AB (publ)
Issue and repurchase of series C shares for share saving program
BONESUPPORT’s FDA notification: Approval on DeNovo pathway for CERAMENT G will require additional data and clarifications